Published Paper Details:

This study aims to evaluate the cash flow performance of Steril-Gene Life Sciences over a five-year period by analysis cash inflows and outflows across operating, investing, and financing activities. Cash flow analysis provides critical insights into the company's liquidity position, financial stability, and overall operational efficiency--especially vital in the intensive pharmaceutical industry. The research utilizes ratio analysis, comparative balance sheets, and correlation testing to interpret financial trends and interdependencies between key indicators such as current ratio, quick ratio, debt-equity ratio, and net profit. Findings reveal a declining trend in liquidity ratios, suggesting short term financial strain, despite a significant improvement in capital structure as reflected by the steady decrease in the debt-equity and debt-to-asset ratios. The company's net profit ratio displayed high volatility, pointing to inconsistent earnings performance. Notably, a strong and statistically significant positive correlation was found between the current ratio and debt-equity ratio, indicating a link between liquidity improvement and equity infusion.